Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson?s associated GBA gene

被引：3

作者：

Chen, Carol X-Q ^{[1
]}

Deneault, Eric ^{[1
]}

Abdian, Narges ^{[1
]}

You, Zhipeng ^{[1
]}

Sirois, Julien ^{[1
]}

Nicouleau, Michael ^{[1
]}

Shlaifer, Irina ^{[1
]}

Villegas, Lorenza ^{[1
]}

Boivin, Marie-Noelle ^{[2
]}

Gaborieau, Lydiane ^{[2
]}

Karamchandani, Jason ^{[2
]}

Beitel, Lenore K. ^{[1
]}

Fon, Edward A. ^{[1
]}

Durcan, Thomas M. ^{[1
]}

机构：

[1] McGill Univ, Neuros Early Drug Discovery Unit EDDU, 3801 Univ St, Montreal, PQ H3A 2B4, Canada

[2] McGill Univ, Montreal Neurol Inst Hosp, C BIG Biorepository C BIG, Montreal, PQ H3A 2B4, Canada

来源：

STEM CELL RESEARCH | 2022年 / 64卷

关键词：

D O I：

10.1016/j.scr.2022.102919

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

The GBA gene encodes the lysosomal enzyme glucocerebrosidase (GCase), responsible for the hydrolysis of glucocerebroside to glucose and ceramide. Heterozygous GBA mutations have been associated with the development of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). We generated two induced pluripotent stem cell (iPSC) lines from PD patients carrying heterozygous GBA W378G or N370S mutations and subsequently produced isogenic control lines using CRISPR/Cas9 genome editing. The patient-derived iPSCs and isogenic control lines maintained full pluripotency, normal karyotypes, and differentiation capacity. All iPSC lines could be differentiated into dopaminergic neurons, thus providing valuable tools for studying PD pathogenesis.

引用

页数：6

共 50 条

[41] Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
Kozhushko, Nikita
Beilina, Aleksandra
Cookson, Mark R.
STEM CELL RESEARCH, 2023, 69
[42] Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
Xu, Xiaohong
Tay, Yilin
Sim, Bernice
Yoon, Su-In
Huang, Yihui
Ooi, Jolene
Utami, Kagistia Hana
Ziaei, Amin
Ng, Bryan
Radulescu, Carola
Low, Donovan
Ng, Alvin Yu Jin
Loh, Marie
Venkatesh, Byrappa
Ginhoux, Florent
Augustine, George J.
Pouladi, Mahmoud A.
STEM CELL REPORTS, 2017, 8 (03): : 619 - 633
[43] Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene
Huang, Di
Zhang, Dan
Chen, Shang-Chih
Aung-Htut, May Thandar
Lamey, Tina M.
Thompson, Jennifer A.
McLaren, Terri L.
De Roach, John N.
Fletcher, Sue
Wilton, Steve D.
Chen, Fred K.
McLenachan, Samuel
STEM CELL RESEARCH, 2021, 54
[44] AAV-mediated gene therapy improves cell viability in a patient-derived induced pluripotent stem cell model of gyrate atrophy
Wilder, Robin
Thu Duong
Yano, Joseph
An, Andrea
Uyhazi, Katherine
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[45] Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11
Hansen, Susanne K.
Borlandb, Helena
Hasholt, Lis F.
Tumer, Zeynep
Nielsen, Jorgen E.
Rasmussen, Mikkel A.
Nielsen, Troels T.
Stummannb, Tina C.
Fog, Karina
Hyttel, Poul
STEM CELL RESEARCH, 2016, 16 (03) : 553 - 556
[46] Generation of a X-linked juvenile retinoschisis patient-derived induced pluripotent stem cell line ZOCi004-A
Zhang, Linyan
Liu, Xinyu
Huang, Mingwei
Xu, Ping
Lai, Yanting
Liu, Yafen
Zhong, Xiufeng
Li, Songshan
Ding, Xiaoyan
STEM CELL RESEARCH, 2022, 65
[47] Generation of induced pluripotent stem cell line derived from FNAIT patient with CD36 deficiency mutations
Chen, Dawei
Wang, Tao
Ye, Xin
Xu, Xiuzhang
Xia, Wenjie
Fu, Yongshui
STEM CELL RESEARCH, 2022, 61
[48] Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells
Son, M. -Y.
Sim, H.
Son, Y. S.
Jung, K. B.
Lee, M. -O.
Oh, J. -H.
Chung, S. -K.
Jung, C. -R.
Kim, J.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2017, 43 (07) : 584 - 603
[49] Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene
Shuvalova, L. D.
Eremeev, A. V.
Bogomazova, A. N.
Novosadova, E. V.
Zerkalenkova, E. A.
Olshanskaya, Yu. V.
Fedotova, E. Y.
Glagoleva, E. S.
Illarioshkin, S. N.
Lebedeva, O. S.
Lagarkova, M. A.
STEM CELL RESEARCH, 2020, 44
[50] Generation and Genetic Correction of Patient-Derived Disease-Specific Human Induced Pluripotent Stem Cells Using Gene Editing Nucleases
Ramalingam, Sivaprakash
Srinivasan, Chandrasegaran
MOLECULAR THERAPY, 2014, 22 : S218 - S219

← 1 2 3 4 5 →